HealthIndustry 3 of 8
In vitro diagnostics
43 EIC Accelerator winners have In vitro diagnostics as their main industry, 10% of Health.
43
Companies
+0
Also active here
7
Sub-industries
24
Technologies used
2%
Exits
30%
Show signs of scaling
Sub-industries
Technologies
- Artificial intelligence15
- Molecular biomarkers8
- Biosensors4
- Microfluidics4
- Bioinformatics3
- Microscopy3
- Nucleic acid testing3
- DNA methylation analysis2
- Electrochemical sensing2
- Flow cytometry2
- Genomic analysis2
- Microarrays2
- PCR2
- Spectroscopy2
- Cloud software1
- CMOS sensors1
- Data analytics1
- Lab automation1
- Medicinal chemistry1
- Optical sensing1
- Photonics1
- Printed electronics1
- Quantum dots1
- Stem cell technology1
Companies per year of first award
2019
2020
2021
2022
2023
2024
- In vitro diagnostics
Show the numbers
| Companies | In vitro diagnostics | |
|---|---|---|
| 2019 | 9 | 9 |
| 2020 | 8 | 8 |
| 2021 | 5 | 5 |
| 2022 | 9 | 9 |
| 2023 | 9 | 9 |
| 2024 | 3 | 3 |
What happened to them (43 of 43 checked)
- Active36 (84%)
- Exit1 (2%)
- Failed5 (12%)
- Other1 (2%)
Signs of scaling
- Scaling13 (30%)
- Not scaling13 (30%)
- Scaling unclear17 (40%)
Keywords
- Allergy testing
- Alzheimer's disease
- Ambulances
- Antibiotic selection
- Antibiotic stewardship
- Antidepressant selection
- Antimicrobial resistance
- Antimicrobial susceptibility testing
- Bacterial infections
- Bacterial or viral infection
- Biomarker analysis
- Biopsy fluid
- Biopsy reduction
- Bladder cancer
- Blood plasma testing
- Blood samples
- Blood test
- Blood testing
- Bloodstream infection
- Bone marrow
- Brain cancer
- Breast cancer
- Breath test
- Cancer immunotherapy
- Cancer metastasis
- Cancer screening
- Checkpoint inhibitors
- Colorectal cancer
- COVID-19
- Digital pathology
- Early detection
- Emergency departments
- Lung cancer
- Oncology
- Prostate cancer
- Rapid diagnostics
- Rare diseases
- RNA sequencing
- Sepsis
- Women's health
All 43 companies in In vitro diagnostics
| Company | Project | Country | Cut-off | Funding | Status | Rasph |
|---|---|---|---|---|---|---|
| ALTRATECH LIMITED | UbiHealthTransforming Molecular Diagnostics through NanoTechnology | Ireland | March 2024 | Blended finance | Active | Deep dive |
| JAXBIO TECHNOLOGIES LTD | LUMENINNOVATIVE LIQUID BIOPSY METHOD USING LAB-ON-ACHIP TECHNOLOGY FOR CANCER DIAGNOSIS AND MANAGEMENT | Israel | March 2024 | Blended finance | Active | Deep dive |
| Omini | CardioCapThe first heart failure therapy management point-of-care device with multiplex and multimodal sensor | France | March 2024 | Blended finance | Active | Deep dive |
| DoMore Diagnostics AS | Histotype PxPrecision biomarker based on digital pathology and artificial intelligence to guide fast and cost-effective personalized treatment decision support for colorectal cancer patients | Norway | November 2023 | Blended finance | Active | Deep dive |
| FASTBASE SOLUTIONS SOCIEDAD LIMITADA | IOO - Improving IOIOO: a novel assay to predict patient response to immune checkpoint inhibitors, optimising patient stratification to these therapies and tripling solid tumour patient outcomes in immuno-oncology. | Spain | November 2023 | Grant first | Active | Deep dive |
| QLUCORE AB | QIandQDThe first IVDR-approved commercial software solutions for AI-powered RNA-based companion and precision cancer diagnostics of acute myeloid leukaemia and bladder cancer | Sweden | November 2023 | Grant only | Active | Deep dive |
| MiMARK Diagnostics, S.L. | WomECReshaping women's health through the understanding of gynecological fluids. WomEC: Antibody-based IVD test based on 5 novel protein biomarkers quantified in liquid biopsy | Spain | March 2023 | Grant first | Active | Deep dive |
| PamGene International BV | ROUTINEcanceR agnOstic immUnoTherapy predIctioN blood-tEst | Netherlands | March 2023 | Blended finance | Active | Deep dive |
| iLoF - Intelligent Lab on Fiber, Lda | iLoFIntelligent Lab on Fiber: AI-augmented photonics to identify and quantify disease biomarkers | Portugal | January 2023 | Blended finance | Active | Deep dive |
| inBiome B.V. | Molecular CultureWorld’s first diagnostic test that can detect all bacterial species in a single assay | Netherlands | January 2023 | Grant first | Active | Deep dive |
| Momentum Bioscience Limited | SepsiSTATDisruptive diagnostic for bacterial infection directly from whole blood in patients with SEPSIS | United Kingdom | January 2023 | Grant only | Insolvent | Deep dive |
| Tampon Innovations Ltd | VMS - Vaginal Microbiome ScreeningCommercialisation and scale up of a Vaginal Microbiome Screening service with a menstrual tampon collection device and a digital layer to provide diagnosis, disease risk evaluation and aftercare. | Bulgaria | January 2023 | Grant first | Active | Deep dive |
| ABCDx SA | LVOCheckDiagnosis of large vessel occlusion (LVO) in acute stroke for improving access to treatment | Spain | October 2022 | Blended finance | Active | Deep dive |
| ALA Diagnostics, S.L. | ALA DIAGNOSTICS MS KITRevolutionising the diagnosis of multiple Sclerosis with the first bioinformatic diagnostic kit that allows early detection with a simple blood test | Spain | October 2022 | Grant first | Active | Deep dive |
| Dxcover Ltd | DXCOVEREarly detection of brain cancer through serum spectroscopy: for much-needed timely detection and diagnosis during the optimal treatment window, when lives can be saved. | United Kingdom | October 2022 | Grant only | Active | Deep dive |
| NEXDOT | NexdiagRevolutionising allergies diagnostics with the next generation of ultra-sensitive highly multiplexed diagnostic tests based on micro-pearls | France | October 2022, May 2026 | Blended finance | Active | Deep dive |
| Vésale Bioscience SPRL | PhagediagFast, easy diagnostics for personalised phage therapy | Belgium | October 2022 | Grant only | Active | Deep dive |
| Metafora Biosystems | METAflowDevelopment and validation of the first digital, clinical grade flow cytometry platform for enhanced diagnosis accuracy and sustainability in immunology and hemato oncology | France | June 2022 | Blended finance | Active | Deep dive |
| Sierra Medical Ltd. | SM-S1New AI-based method for early detection of lung cancer. | United Kingdom | June 2022 | Grant only | Active | Deep dive |
| Dermagnostix GmbH | DERMAGNOSTIXPioneering diagnostics in dermatology and cancer | Germany | March 2022 | Grant first | Active | Deep dive |
| GenetikaPlus Ltd | RxMineA simple blood test to choose the best treatment for each patient with depression. | Israel | March 2022 | Grant first | Active | Deep dive |
| ADVANCED MARKER DISCOVERY SL | ColoDixEarly detection of colorectal cancer in blood based on latest generation biomarkers and Artificial Intelligence tools | Spain | October 2021 | Grant first | Active | Deep dive |
| SEQUENTIA BIOTECH SL | MICKTranslational Microbiome Platform | Spain | October 2021 | Blended finance | Active | Deep dive |
| enGenome srl | eVaiA novel bioinformatics SaaS platform to identify and classify the pathogenicity of single genomic variants and oligogenic variant combinations for the diagnosis and treatment of genetic diseases | Italy | June 2021 | Grant first | Active | Deep dive |
| GLYCANOSTICS SRO | ProSCANProstate cancer diagnostics using a non-invasive test based on innovative glycan-based scanning | Slovakia | June 2021 | Grant first | Active | Deep dive |
| RUBYNANOMED, UNIPESSOAL LDA | BRIGHTBest-in-class cancer dIagnostic chip for patient stratification. | Portugal | June 2021 | Blended finance | Active | Deep dive |
| EMPE Diagnostics AB | mfloDxAn Adaptable Multiflow Diagnostic Platform to Genetically Identify Drug Resistant Infection | Sweden | October 2020 | Grant only | Active | Deep dive |
| Novus Diagnostics Limited | SepTecNext generation Sepsis pathogen diagnostics: Revolutionary device for rapid detection of Sepsis | Ireland | October 2020 | Blended finance | Active | Deep dive |
| ADmit Therapeutics S.L. | MAP-ADA Methylation Profiling Diagnostic for Early Diagnosis of Alzheimer’s disease | Spain | March 2020 | Blended finance | Active | Deep dive |
| MindPeak GmbH | AIPACAAI-powered pathological cancer diagnostics | Germany | March 2020 | Grant only | Active | Deep dive |
| NanoScent Ltd | NanoScent COVID- 19Novel COVID-19 POC Screening Tool Based on Proprietary Nano-Sensors and ML Techniques | Israel | March 2020 | Grant only | Insolvent | Deep dive |
| Resistell AG | RAPID-SEP-ASTRapid diagnostic for bacterial SEPSIS and AMR urgently needed for ICU patients in COVID-19-like epidemics | Switzerland | March 2020 | Grant only | Active | Deep dive |
| SOMAPROBES SL | Corona-QuickRapid and easy- test for Coronavirus infections | Spain | March 2020 | Grant only | Insolvent | Deep dive |
| ViroGates A/S | RISCinCOVIDOptimal use of hospital resources and intervention using suPAR for improving prognosis and care for patients with COVID-19 | Denmark | March 2020 | Grant only | Active | Deep dive |
| MultiplexDX, s.r.o. | Multiplex8+A highly accurate breast cancer diagnostic test for effective personalized treatment and assessment of therapy response. | Slovakia | October 2019 | Grant only | Active | Deep dive |
| OPHIOMICS - INVESTIGAÇÃO E DESENVOLVIMENTO EM BIOTECNOLOGIA, S.A. | HepatoPredictHepatoPredict, A decision tool for Liver Transplantation based on molecular signature | Portugal | October 2019 | Blended finance | Active | Deep dive |
| Smart4Diagnostics GmbH | S4DXThe world’s first “digital data-fingerprint” for human blood samples. | Germany | October 2019 | Blended finance | Insolvent | Deep dive |
| Aiforia Technologies Oyj | AiforCancerDXDeep learning AI in cancer diagnostics | Finland | June 2019 | Grant only | Listed | Deep dive |
| Bacteromic sp. z o.o. | BacterOMICIntelligence for precision therapies against antimicrobial resistance: The first diagnostic panel that probes all the clinically relevant antibiotics at once | Poland | June 2019 | Grant only | Active | Deep dive |
| MEMED DIAGNOSTICS LTD | DECODEreDucing the health and Economic COst of Diagnostic uncErtainty: launch and randomized control trial of the first validated bacterial versus viral test | Israel | June 2019 | Grant only | Active | Deep dive |
| NANOSYNEX LTD | NanosynexUltra-fast Antimicrobial Susceptibility Test for diagnosing antimicrobial resistance to provide personalized antibiotic treatments | Israel | June 2019, March 2020 | Grant only | Unknown | Deep dive |
| SPOTLAB SL | SpotLabImmediate, ubiquitous and affordable image diagnosis combining the power of AI, smartphones and 3d printing to achieve Universal Diagnosis by 2030 | Spain | June 2019 | Grant only | Active | Deep dive |
| GENOSMART LTD | MMEMMiniaturized Matrixed Enthalpy Metter - Portable, affordable, easy to operate, diagnostic device enabling a rapid & accurate diagnosis of a patient infected by antibiotic-resistant bacteria | Israel | January 2019 | Grant only | Closed | Deep dive |
Other industries in Health: Medical devices · Biopharmaceuticals · Life science tools · Digital health · Animal health · Public health products · Pharmacy technology